share_log

6-K: Transaction Notification

SEC ·  Dec 23, 2024 17:56

Summary by Futu AI

On December 20, 2024, multiple GSK directors and executives executed significant share purchases on both London Stock Exchange and NYSE. Senior Independent Non-Executive Director Charles Bancroft made the largest purchase of 2,184 ADSs at $33.8097 per share, while Lady Susan Symonds, PCA of Non-Executive Chair, acquired 1,500 ordinary shares at £13.1508.Other notable transactions included Independent Non-Executive Director Dr. Vishal Sikka's purchase of 937 ADSs, and Wendy Becker's acquisition of 546 ordinary shares at £13.1900. Multiple board members, including Dr. Hal Barron, Dr. Anne Beal, Dr. Hal Dietz, Dr. Jesse Goodman, and Dr. Jeannie Lee, each purchased 271-272 ADSs at $33.8097 per share.
On December 20, 2024, multiple GSK directors and executives executed significant share purchases on both London Stock Exchange and NYSE. Senior Independent Non-Executive Director Charles Bancroft made the largest purchase of 2,184 ADSs at $33.8097 per share, while Lady Susan Symonds, PCA of Non-Executive Chair, acquired 1,500 ordinary shares at £13.1508.Other notable transactions included Independent Non-Executive Director Dr. Vishal Sikka's purchase of 937 ADSs, and Wendy Becker's acquisition of 546 ordinary shares at £13.1900. Multiple board members, including Dr. Hal Barron, Dr. Anne Beal, Dr. Hal Dietz, Dr. Jesse Goodman, and Dr. Jeannie Lee, each purchased 271-272 ADSs at $33.8097 per share.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 312

Recommended